CLINICAL INFRASTRUCTURE FOR FINANCIAL TOXICITY

Make financial toxicity visible, trackable, and treatable in oncology.

Healing, not billing.

Hinto screens every oncology patient for financial distress at intake, auto-stratifies risk, and routes high-risk patients to navigators before costs derail care. No new FTEs, no extra portals—just a workflow your team can actually run.

Built for oncology practices, financial navigators, and patient advocacy partners.

Book a 20-minute discovery call →

Supported by the National Cancer Institute (NCI) Small Business Transition Grant (STEP) program.

Built on Clinical Evidence, Not Startup Assumptions

Financial toxicity is a clinical complication—not a billing problem. Our research infrastructure treats it as such.

Validated Screening at Point of Care

We integrate COST-FACIT—the gold-standard measure of cancer-related financial distress—directly into oncology intake workflows. Automated risk stratification identifies high, moderate, and low-risk patients in real time, with minimal staff burden.

Target: ≥80% screening completion, ≤3 minutes per patient

Risk-Stratified Navigation Pathways

High-risk patients trigger mandatory navigator follow-up within 24 hours. Moderate-risk patients enter structured benefit optimization workflows. Low-risk patients receive standard information with passive monitoring—no one falls through the cracks.

Hypothesis: 25-30% reduction in treatment abandonment among high-risk cohorts

Equity-Enforced Design

All patients screened using identical validated instruments. Risk triage calculated solely from self-reported COST scores—no demographic variables. High-risk flags trigger mandatory response protocols, tracked and audited by the system to prevent selective navigation.

Monitored: screening rates, triage distribution, outcomes by race/ethnicity/insurance

Why This Matters to Your Organization

For CFOs & Practice Administrators

Revenue protection: Reduce write-offs and improve collections in high-risk cohorts by identifying distress before it becomes bad debt
Navigator efficiency: Increase effective capacity by 40-50% without additional FTEs through automated triage and application workflows
Compliance & equity: Demonstrate standardized, auditable financial distress screening aligned with national oncology guidelines

For Financial Navigators

Proactive workflows: Stop chasing crises—patients are flagged and routed to you before bills spiral
Application automation: Deadline tracking, document checklists, and program matching reduce administrative overhead
Outcome visibility: Track FT score changes, assistance dollars secured, and treatment continuity to prove impact

For Clinical Directors & Quality Leads

Treatment continuity: Reduce abandonment and delays by addressing financial barriers at intake, not after the first missed infusion
Standard of care: Operationalize NCCN and ASCO guidelines for routine financial toxicity screening
Population health data: Generate clinic-level FT metrics to inform care delivery redesign and value-based contracts

Our Thesis

Financial toxicity is the sixth vital sign in oncology. It predicts treatment adherence, quality of life, and survival—yet most clinics still treat it as a billing issue rather than a clinical risk factor.

Hinto makes financial distress measurable, triageable, and trackable at the point of care. We're not replacing navigators—we're building the infrastructure that makes their work scalable, equitable, and evidence-based. This is clinical decision support for a side effect no one should die from.